#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Parkinson's disease Cytokine release syndrome Richter's syndrome Narcolepsy Diffuse large B-cell lymphoma Urea cycle disorder Spina bifida Neuroendocrine tumour Acute graft versus host disease in skin Osteomyelitis Ocular myasthenia Aicardi-Goutieres syndrome Skin cancer Waldenstrom's macroglobulinaemia refractory Blastic plasmacytoid dendritic cell neoplasia More trials…

    Learn about Rare Diseases

    Gaucher’s disease type III – Treatment Marfan’s syndrome – Basic Information Osteosarcoma recurrent – Diagnostics Netherton’s syndrome – Life with Disease Sjogren’s syndrome – Life with Disease Pleural mesothelioma malignant – Life with Disease Pulmonary sarcoidosis Glycogen storage disease type I – Diagnostics Small intestine leiomyosarcoma – Life with Disease Ehlers-Danlos syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    METAMIZOLE SODIUM Oditrasertib Amifostine Thiol Lixisenatide Povetacicept Gen3017 INSULIN DETEMIR Ciclesonide Vamorolone Rosuvastatin Calcium Nofazinlimab HUMAN FIBROBLASTS Gedatolisib Fosphenytoin Sodium Remimazolam Aluminium Bt-001 GSKVX000000044501 Ng004 Vonafexor More therapies…

    Learn about Your Condition

    Oedema peripheral Acute on chronic liver failure Infection Acute respiratory failure Nervous system disorder Rectal cancer recurrent Tuberous sclerosis complex End stage renal disease Tendon disorder Mumps Medication overuse headache Adenocarcinoma Retinoblastoma Labour pain Cervix carcinoma stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Juvenile idiopathic arthritis

  • Study Comparing Step-up and Step-down Treatment Strategies with Methotrexate and Etanercept for Children with Juvenile Idiopathic Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Etanercept
    • Methotrexate
    Italy

  • Study on the Safety and Effectiveness of Baricitinib for Children Aged 1 to 17 with Juvenile Idiopathic Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Baricitinib
    Austria Belgium Czechia Denmark France Germany +3

  • Study on Upadacitinib and Tocilizumab for Children and Teens with Active Systemic Juvenile Idiopathic Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Tocilizumab
    • Upadacitinib
    Austria Belgium Germany Hungary Italy The Netherlands +2

  • Study on the Safety and Body Processing of Bimekizumab in Children with Juvenile Idiopathic Arthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    • Juvenile spondyloarthritis
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Bimekizumab
    France Germany Poland Spain

  • Study on Early Drug Withdrawal in Children with Juvenile Idiopathic Arthritis Using Secukinumab and Drug Combination for Those in Clinical Remission

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Secukinumab
    • Baricitinib
    • Abatacept
    Belgium Czechia Denmark Italy Lithuania Portugal +1

  • Study on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis

    Recruiting

    3 1 1 1 1
    Investigated Drugs:
    • Secukinumab
    Belgium Bulgaria Czechia Germany Italy Poland +2
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!